United HealthCare And Humana Plan $5.5 Billion Merger United HealthCare and Humana, two of the nation’s largest for-profit managed care companies, have agreed to a $5.5 billion merger. The resulting company will operate as United HealthCare in 48 states and Puerto Rico.
The move is one of the largest instances yet of the consolidation taking place in the managed care industry. When con- summated this fall — assuming regulatory and shareholder approval — the merger will create a behemoth with 6 million enrollees, with the majority of them in the Midwest, Southeast and Southwest.
Also on the sale-and-merger beat: Kaiser Permanente will unload its money-losing Texas operations to Sierra Health Services. Las Vegas-based Sierra, which already has a solid foothold in the Texas market, will pick up Kaiser’s 123,000 Dallas-area subscribers and a 150-physician group for an undisclosed sum.
- Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness.
- Er schreibt bereits seit über 5 Jahren für das Managed Care Mag.
- Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.
: United HealthCare And Humana Plan $5.5 Billion Merger
Who merged with Humana?
Aetna and Humana Mutually End Merger Agreement. We enter our 60th year as one of the most trusted brands in America.
Is Humana the same as Medicare?
What is a Medicare Advantage plan? Medicare Advantage plans are offered by private insurance companies—like Humana—contracted by the federal government. Medicare Advantage, also referred to as Medicare Part C, covers the same healthcare services as Original Medicare, except for hospice care.
How many locations does Humana have?
Humana is headquartered in Louisville, 500 W Main St, United States, and has 77 office locations. Locations.
| Country | City | Address |
|---|---|---|
| United States | Atlanta | 1200 Ashwood Pkwy #180 |
| United States | Baton Rouge | 10330 Airline Hwy b1 |
| United States | Biloxi | 2650 Beach Blvd #31a |
| United States | Boynton Beach | 801 N Congress Ave |
Is Humana part of United?
United HealthCare And Humana Plan $5.5 Billion Merger United HealthCare and Humana, two of the nation’s largest for-profit managed care companies, have agreed to a $5.5 billion merger. The resulting company will operate as United HealthCare in 48 states and Puerto Rico.
The move is one of the largest instances yet of the consolidation taking place in the managed care industry. When con- summated this fall — assuming regulatory and shareholder approval — the merger will create a behemoth with 6 million enrollees, with the majority of them in the Midwest, Southeast and Southwest.
Also on the sale-and-merger beat: Kaiser Permanente will unload its money-losing Texas operations to Sierra Health Services. Las Vegas-based Sierra, which already has a solid foothold in the Texas market, will pick up Kaiser’s 123,000 Dallas-area subscribers and a 150-physician group for an undisclosed sum.
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.
: United HealthCare And Humana Plan $5.5 Billion Merger
Who is the largest shareholder of Humana?
Shareholders
| Name | SEK t | |
|---|---|---|
| 1 | IMPILO CARE AB | 180 639 |
| 2 | THE BANK OF NEW YORK MELLON SA/NV, W8IMY | 90 059 |
| 3 | VERDIPAPIRFONDET NORDEA NORGE VERDI | 39 860 |
| 4 | SEB AB, LUXEMBOURG BRANCH, W8IMY | 32 276 |
What does Humana mean?
Humana f (plural humanas) (Sursilvan) female equivalent of human; female human being synonym ▲ Synonym: carstgauna.
What country is Humana from?
From Wikipedia, the free encyclopedia This article is about the health insurance company. For other uses, see Humana (disambiguation),
| Type | Public |
|---|---|
| Traded as |
|
| Industry | Managed health care |
| Founded | August 18, 1961 ; 61 years ago (as Extendicare Inc.) Louisville, Kentucky, U.S. |
| Founder | Wendell Cherry |
| Headquarters | Louisville, Kentucky, U.S. |
| Key people |
|
| Revenue | US$ 83.06 billion (2021) |
| Operating income | US$3.15 billion (2021) |
| Net income | US$2.93 billion (2021) |
| Total assets | US$44.36 billion (2021) |
| Total equity | US$16.10 billion (2021) |
| Number of employees | 95,500 (December 2021) |
| Website | www,humana,com |
Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky, In 2021, the company ranked 41 on the Fortune 500 list, which made it the highest ranked (by revenues) company based in Kentucky, It has been the third largest health insurance provider in the nation.
Where is Humana headquarters in the US?
Humana is headquartered in Louisville, Kentucky, the US.
What is the summary of Humana?
The Humana Member Summary is a tool that displays patient-specific, clinically relevant information in a standardized format to assist you in identifying opportunities to improve clinical outcomes and reduce medically related costs.
Does BlackRock own Humana?
Fintel reports that BlackRock Inc. has filed a 13G/A form with the SEC disclosing ownership of 11.63MM shares of Humana Inc ( HUM ). This represents 9.2% of the company. In their previous filing dated June 9, 2022 they reported 12.73MM shares and 10.10% of the company, a decrease in shares of 8.68% and a decrease in total ownership of 0.90% (calculated as current – previous percent ownership).
Analyst Price Forecast Suggests 25.38% Upside As of January 24, 2023, the average one-year price target for Humana is $627.35. The forecasts range from a low of $520.15 to a high of $695.10. The average price target represents an increase of 25.38% from its latest reported closing price of $500.35. The projected annual revenue for Humana is $102,529MM, an increase of 12.07%.
The projected annual EPS is $28.32, an increase of 28.29%. Fund Sentiment There are 2111 funds or institutions reporting positions in Humana Inc. This is an increase of 93 owner(s) or 4.61%. Average portfolio weight of all funds dedicated to Humana Inc is 0.5118%, an increase of 7.1905%. 
Wellington Management Group Llp holds 8,975,686 shares representing 7.09% ownership of the company. In it’s prior filing, the firm reported owning 9,396,515 shares, representing a decrease of 4.69%. The firm increased its portfolio allocation in HUM by 4.72% over the last quarter.
Price T Rowe Associates Inc /md/ holds 6,792,073 shares representing 5.36% ownership of the company. In it’s prior filing, the firm reported owning 7,572,451 shares, representing a decrease of 11.49%. The firm increased its portfolio allocation in HUM by 20.79% over the last quarter. Capital International Investors holds 3,338,129 shares representing 2.64% ownership of the company.
In it’s prior filing, the firm reported owning 3,359,881 shares, representing a decrease of 0.65%. The firm increased its portfolio allocation in HUM by 10.46% over the last quarter. Capital Research Global Investors holds 2,838,670 shares representing 2.24% ownership of the company.
In it’s prior filing, the firm reported owning 3,890,140 shares, representing a decrease of 37.04%. The firm decreased its portfolio allocation in HUM by 20.21% over the last quarter. Geode Capital Management, Llc holds 2,167,946 shares representing 1.71% ownership of the company. In it’s prior filing, the firm reported owning 2,098,680 shares, representing an increase of 3.20%.
The firm increased its portfolio allocation in HUM by 10.96% over the last quarter. Humana Declares $0.79 Dividend Humana said on October 27, 2022 that its board of directors declared a regular quarterly dividend of $0.79 per share ($3.15 annualized).
- Shareholders of record as of December 29, 2022 will receive the payment on January 27, 2023.
- Previously, the company paid $0.79 per share.
- At the most recent share price of $500.35 / share, the stock’s dividend yield was 0.63%.
- Additionally, the company’s dividend payout ratio is 0.14, indicating it is retaining a low percentage of its earnings to reinvest in growth opportunities.
The company’s 3-Year dividend growth rate is 0.43%, demonstrating that it is increasing its dividends over time. Humana Inc. Background Information (This description is provided by the company.) Humana Inc. is committed to helping its millions of medical and specialty members achieve their best health.
- Its successful history in care delivery and health plan administration is helping it create a new kind of integrated care with the power to improve health and well-being and lower costs.
- Its efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.
This story originally appeared on Fintel, The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Who is the head of strategy for Humana?
Vishal Agrawal, M.D. He is responsible for leading Humana’s corporate strategy, as well as setting the direction of the company’s merger and acquisition and joint venture activities.
Who are Humana stock competitors?
HUM vs. CNC, ELV, MOH, GSK, BDX, BSX, HCA, EW, TAK, and ZTS – Should you be buying Humana stock or one of its competitors? The main competitors of Humana include Centene (CNC), Elevance Health (ELV), Molina Healthcare (MOH), GSK (GSK), Becton, Dickinson and (BDX), Boston Scientific (BSX), HCA Healthcare (HCA), Edwards Lifesciences (EW), Takeda Pharmaceutical (TAK), and Zoetis (ZTS).
These companies are all part of the “medical” sector. Centene ( NYSE:CNC ) and Humana ( NYSE:HUM ) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends, profitability and community ranking.
Humana has a net margin of 3.26% compared to Centene’s net margin of 1.01%. Humana’s return on equity of 21.04% beat Centene’s return on equity.
| Company | Net Margins | Return on Equity | Return on Assets |
|---|---|---|---|
| Centene | 1.01% | 13.61% | 4.28% |
| Humana | 3.26% | 21.04% | 6.87% |
In the previous week, Humana had 3 more articles in the media than Centene. MarketBeat recorded 38 mentions for Humana and 35 mentions for Centene. Humana’s average media sentiment score of 0.51 beat Centene’s score of 0.41 indicating that Humana is being referred to more favorably in the news media.
| Company | Very Positive | Positive | Neutral | Negative | Very Negative | Overall Sentiment |
|---|---|---|---|---|---|---|
| Centene | 9 Very Positive mention(s) | 3 Positive mention(s) | 11 Neutral mention(s) | 1 Negative mention(s) | 0 Very Negative mention(s) | Neutral |
| Humana | 6 Very Positive mention(s) | 3 Positive mention(s) | 12 Neutral mention(s) | 0 Negative mention(s) | 0 Very Negative mention(s) | Positive |
Centene presently has a consensus target price of $92.00, suggesting a potential upside of 35.08%. Humana has a consensus target price of $597.37, suggesting a potential upside of 12.16%. Given Centene’s higher probable upside, equities analysts clearly believe Centene is more favorable than Humana.
| Company | Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
|---|---|---|---|---|---|
| Centene | 1 Sell rating(s) | 5 Hold rating(s) | 12 Buy rating(s) | 0 Strong Buy rating(s) | 2.61 |
| Humana | 0 Sell rating(s) | 2 Hold rating(s) | 15 Buy rating(s) | 0 Strong Buy rating(s) | 2.88 |
Centene has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500. Centene received 141 more outperform votes than Humana when rated by MarketBeat users.
| Company | Underperform | Outperform |
|---|---|---|
| Centene | Outperform Votes 992 73.70% | Underperform Votes 354 26.30% |
| Humana | Outperform Votes 851 64.71% | Underperform Votes 464 35.29% |
Humana has lower revenue, but higher earnings than Centene. Humana is trading at a lower price-to-earnings ratio than Centene, indicating that it is currently the more affordable of the two stocks.
| Company | Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
|---|---|---|---|---|---|
| Centene | $144.55 billion | 0.26 | $1.20 billion | $2.64 | 25.80 |
| Humana | $92.87 billion | 0.72 | $2.81 billion | $24.62 | 21.63 |
93.3% of Centene shares are owned by institutional investors. Comparatively, 93.4% of Humana shares are owned by institutional investors.0.3% of Centene shares are owned by insiders. Comparatively, 0.3% of Humana shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
What is the Humana Inc controversy?
Learn How Our Insurance Lawyers Can Help You Take Legal Action – Health insurance companies like Humana Inc. provide coverage for life’s unexpected accidents. Insurance can cover a broad range of medical issues. Disability insurance can also play a significant role in helping a family stay afloat when the provider can no longer work due to a serious injury or illness.
However, the process of obtaining benefits from an insurance company is not always so simple. Like many providers, Humana does not have a clean rap sheet. The company has been in the news frequently for a variety of issues, including claims that it overcharged for its Medicare Advantage program, failed to provide accurate beneficiary information, and improperly collected refunds from healthcare providers.
Humana was even ordered to pay more than $1 million for violating the Fair Labor Standards Act. Has your claim been denied or mishandled by Humana Inc.? Contact our insurance claim attorneys at (888) 493-1629, Here’s why you can trust Arnold & Itkin to handle your case against Humana:
Billions of dollars recovered for our clients Award-winning, record-breaking legal representation Respect from judges, peers, and professionals Dedicated to your best interests at every step
What is the new name of Kindred?
‘The rebrand to CenterWell Home Health also creates a lot of optimism in our future because we are becoming part of a growing, national brand that’s focused on providing better experiences not only to patients and their families, but to frontline clinicians too,’ Shane added.
Who bought Kindred?
LifePoint Health purchases post-acute services company Kindred Healthcare, commits to 3-year, $1.5B investment | Fierce Healthcare. What are you searching for? Enclose phrases in quotes. Use a + to require a term in results and – to exclude terms.
Who are Humana stock competitors?
HUM vs. CNC, ELV, MOH, GSK, BDX, BSX, HCA, EW, TAK, and ZTS – Should you be buying Humana stock or one of its competitors? The main competitors of Humana include Centene (CNC), Elevance Health (ELV), Molina Healthcare (MOH), GSK (GSK), Becton, Dickinson and (BDX), Boston Scientific (BSX), HCA Healthcare (HCA), Edwards Lifesciences (EW), Takeda Pharmaceutical (TAK), and Zoetis (ZTS).
- These companies are all part of the “medical” sector.
- Centene ( NYSE:CNC ) and Humana ( NYSE:HUM ) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends, profitability and community ranking.
Humana has a net margin of 3.26% compared to Centene’s net margin of 1.01%. Humana’s return on equity of 21.04% beat Centene’s return on equity.
| Company | Net Margins | Return on Equity | Return on Assets |
|---|---|---|---|
| Centene | 1.01% | 13.61% | 4.28% |
| Humana | 3.26% | 21.04% | 6.87% |
In the previous week, Humana had 3 more articles in the media than Centene. MarketBeat recorded 38 mentions for Humana and 35 mentions for Centene. Humana’s average media sentiment score of 0.51 beat Centene’s score of 0.41 indicating that Humana is being referred to more favorably in the news media.
| Company | Very Positive | Positive | Neutral | Negative | Very Negative | Overall Sentiment |
|---|---|---|---|---|---|---|
| Centene | 9 Very Positive mention(s) | 3 Positive mention(s) | 11 Neutral mention(s) | 1 Negative mention(s) | 0 Very Negative mention(s) | Neutral |
| Humana | 6 Very Positive mention(s) | 3 Positive mention(s) | 12 Neutral mention(s) | 0 Negative mention(s) | 0 Very Negative mention(s) | Positive |
Centene presently has a consensus target price of $92.00, suggesting a potential upside of 35.08%. Humana has a consensus target price of $597.37, suggesting a potential upside of 12.16%. Given Centene’s higher probable upside, equities analysts clearly believe Centene is more favorable than Humana.
| Company | Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
|---|---|---|---|---|---|
| Centene | 1 Sell rating(s) | 5 Hold rating(s) | 12 Buy rating(s) | 0 Strong Buy rating(s) | 2.61 |
| Humana | 0 Sell rating(s) | 2 Hold rating(s) | 15 Buy rating(s) | 0 Strong Buy rating(s) | 2.88 |
Centene has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.72, suggesting that its share price is 28% less volatile than the S&P 500. Centene received 141 more outperform votes than Humana when rated by MarketBeat users.
| Company | Underperform | Outperform |
|---|---|---|
| Centene | Outperform Votes 992 73.70% | Underperform Votes 354 26.30% |
| Humana | Outperform Votes 851 64.71% | Underperform Votes 464 35.29% |
Humana has lower revenue, but higher earnings than Centene. Humana is trading at a lower price-to-earnings ratio than Centene, indicating that it is currently the more affordable of the two stocks.
| Company | Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
|---|---|---|---|---|---|
| Centene | $144.55 billion | 0.26 | $1.20 billion | $2.64 | 25.80 |
| Humana | $92.87 billion | 0.72 | $2.81 billion | $24.62 | 21.63 |
93.3% of Centene shares are owned by institutional investors. Comparatively, 93.4% of Humana shares are owned by institutional investors.0.3% of Centene shares are owned by insiders. Comparatively, 0.3% of Humana shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.